last
decad
numer
report
deal
felv
vaccin
includ
use
crude
vaccin
made
solubl
product
viru
infect
cell
math
et
al
whole
live
dead
felv
infect
tumor
cell
jarrett
et
al
olsen
et
al
inactiv
whole
felv
olsen
et
al
pedersen
et
al
yohn
et
al
live
viru
hardi
pedersen
et
al
viral
envelop
subunit
protein
salerno
et
al
efficaci
variou
vaccin
test
measur
acquisit
viru
neutral
antibodi
salerno
et
al
challeng
cat
fibrosarcoma
viru
prepar
olsen
et
al
yohn
et
al
virul
felv
hardi
hoover
et
al
jarrett
et
al
jarrett
et
al
contact
exposur
chronic
infect
cat
pedersen
et
al
vaccin
protect
cat
infect
virul
viru
other
present
emphasi
felv
vaccin
research
genet
engin
viral
subunit
protein
either
form
bacteri
yeast
express
product
synthet
oligopeptid
among
variou
viru
structur
protein
dalton
envelop
glycoprotein
thought
respons
evok
protect
niti
cat
hardi
salerno
et
al
mice
marin
leukemia
viru
coval
link
dalton
transenvelop
anchor
protein
shown
even
immunogen
alon
hunsmann
et
al
use
genet
engin
part
protein
synthes
bacteria
yeast
chemic
produc
small
inunogen
polypeptid
contain
pertin
antigen
epitop
lerner
nunberg
et
al
previou
experi
retroviru
subunit
vaccin
cowork
inmniz
mice
friend
marin
leukemia
viru
use
purifi
viral
envelop
protein
complex
similar
prepar
use
immun
cat
snydertheilen
fibrosarcoma
viru
stfesv
induc
tumor
hunsmann
et
al
felin
leukemia
immunogen
cat
inmmiz
cat
develop
smaller
tumor
nonvaccin
anim
data
present
howev
retroviremia
accompani
tumor
growth
salerno
associ
fail
induc
neutral
antibodi
cat
dose
purifi
produc
good
neutral
antibodi
titer
guinea
pig
efficaci
vaccin
virul
felv
challeng
exposur
test
howev
essenti
success
genet
engin
subunit
felv
vaccin
first
determin
whether
nativ
viral
subunit
imaunogen
importantli
whether
cat
immun
nativ
viral
subunit
protein
protect
virul
felv
challeng
exposur
reason
follow
experi
conduct
experi
cat
immun
inmlmoaffin
colunn
purifi
chemic
purifi
challeng
variou
way
virul
felv
fesv
control
studi
cat
either
left
unimmun
vaccin
formalin
inactiv
purifi
whole
felv
formalin
inactiv
whole
felv
vaccin
previous
shown
laboratori
effect
irmmmogen
prevent
persist
felv
infect
follow
natur
exposur
pedersen
et
al
experiment
studi
report
herein
indic
infect
virul
felv
may
actual
enhanc
preimmun
vaccin
challengeexposur
situat
inactiv
whole
felv
vaccin
protect
kitten
week
age
obtain
specif
pathogen
kawakamitheilen
strain
felv
produc
cultur
felin
lyphoblastoid
oell
theilen
et
al
strain
actual
mixtur
subgroup
b
c
virus
sarma
et
al
snydertheilen
strain
felv
stfelv
isol
cat
remain
retrovirem
recov
tumor
induc
stfelin
sarcoma
viru
stfesv
buffi
ooat
oell
blood
cat
cocultiv
primari
fibrcblast
cell
result
infect
cultur
design
stfelv
natur
occur
helper
viru
present
stfesv
stock
belong
interfer
subgroup
b
sarma
et
al
stfelv
isol
nontransform
normal
felin
fibroblast
induc
fibrosarcoma
strain
felv
natur
occur
subgroup
retroviru
isol
leopard
cat
live
household
felv
infect
domest
cat
rashe
et
al
viru
replic
chronic
fashion
leopard
cat
testicl
cell
rickard
strain
felv
rfelv
rickard
et
al
origin
obtain
cellfre
tumor
homogen
dr
richard
olsen
ohio
state
univers
isol
classifi
subgroup
sarma
et
al
assay
three
felv
structur
protein
quantiti
doubl
sandwich
type
enzym
link
inmlznosorh
assay
elisa
assay
procedur
ident
describ
lutz
cowork
similar
assay
use
quantit
felv
assay
util
polyclon
goat
antifelv
oglobulin
nih
catcher
monoclon
mous
igg
conjug
hors
radish
peroxidas
hpase
second
antibodi
elisa
util
monoclon
mous
anti
igg
catcher
monoclon
mous
antifelv
plse
igg
conjug
hpase
second
antibodi
igg
fraction
purifi
serum
ascit
fluid
procedur
bruck
cowork
assay
procedur
use
follow
variou
step
purif
assur
separ
assay
also
use
detect
viru
blood
felv
infect
cat
purif
prepar
ktfelv
stfelv
use
lmmunoaffin
olumn
chromatographi
viru
contain
cell
cultur
supernat
clarifi
particul
debri
low
speed
centrifug
concentr
fold
milipor
pellicon
apparatu
viru
pellet
rpm
min
beckman
type
rotor
beckman
instrument
palo
alto
ca
pellet
viru
resuspend
small
amount
ten
buffer
tri
edta
naci
ph
place
continu
sucros
gradient
centrifug
rpm
hr
beckman
rotor
gradient
fraction
collect
assay
elisa
fraction
oontain
largest
anount
protein
save
fig
figur
continu
sucros
gradient
purif
felv
pellet
concentr
clarifi
tissu
cultur
media
protein
determin
elisa
assay
concentr
near
gml
region
gradient
correspond
area
whole
virion
band
viru
remov
sucros
dilut
gradient
fraction
ten
buffer
reultracentrifug
pellet
resuspend
ten
buffer
contain
triton
triton
disrupt
viru
pass
inmlmoaffin
collmm
immunoaffin
column
made
accord
procedur
cuatrecas
use
cyanogen
bromid
activ
mous
monoclon
igg
differ
epitop
monoclon
antibodi
nonbind
protein
wash
coltmm
larg
volum
ten
buffer
elut
materi
free
fig
fi
immunoaffin
column
purif
column
made
sepharos
coval
link
mous
monoclon
igg
start
materi
column
deterg
disrupt
whole
felv
appear
colunm
washthrough
wash
buffer
free
protein
kscn
gradient
start
elut
kscn
elut
continu
gradient
sodium
thiocyan
mm
borat
buffer
ph
result
eluat
fraction
assay
fraction
contain
greatest
amount
materi
pool
fig
rich
eluat
desalt
sephadex
column
equilibr
ram
ammonium
bicarbon
buffer
ph
purif
sett
made
coval
link
felv
envelop
protein
produc
ktfelv
procedur
describ
bnsmann
cowork
schneider
associ
rosett
assay
sdspaq
major
protein
band
demonstr
coomassi
blue
stain
dalton
rosett
run
reduc
gel
laemmli
dalton
protein
reduc
dalton
protein
serum
antibodi
whole
felv
measur
elisa
procedur
well
microtit
plate
imulon
dynatech
laboratori
inc
alexandria
va
well
coat
hr
c
either
ng
gradient
purifi
sodium
dodecylsulph
disrupt
felv
ng
inminoaffin
col
purifi
ng
purifi
buffer
ph
serum
test
dilut
whole
felv
trisedta
salin
buffer
tween
bovin
serum
albumin
ph
dilut
serum
incub
antigen
coat
well
hr
c
wash
dilut
rabbit
anticat
igg
hors
radish
peroxidas
conjug
cappel
laboratori
cochranvil
pa
allow
react
min
well
wash
enzymat
reaction
carri
abt
color
reaction
read
dynatech
microelisa
reader
dynatech
laboratori
inc
alexandria
va
optic
densiti
read
standard
known
posit
neg
serum
includ
test
run
viru
neutral
antibodi
measur
infect
inhibit
assay
subconflu
monolay
crandel
felin
kidney
crfk
cell
establish
well
microtit
plate
one
hundr
tissu
cultur
infecti
dose
ktor
ml
tissu
cultur
media
incub
hr
c
equal
volum
serial
twofold
dilut
test
cat
serum
start
specif
pathogen
free
cat
serum
use
neg
control
goat
antifelv
serum
posit
control
incub
serumviru
mixtur
overlay
onto
crfk
cell
monolay
incub
hour
time
media
complet
chang
tissu
cultur
supernat
harvest
day
assay
antigen
titer
viru
neutral
antibodi
given
serum
score
reciproc
highest
dilut
serum
complet
suppress
express
iunogenec
purifi
test
elisa
two
differ
basic
challeng
system
use
test
efficaci
variou
vaccin
prepar
first
system
cat
inocul
subcutan
shoulder
blade
x
cell
cell
line
primari
felin
fibroblast
cultur
product
transform
stfesv
fibrosarcoma
appear
site
inocul
within
day
concurr
system
retroviru
infect
system
retroviremia
shown
due
almost
exclus
felv
helper
viru
present
stfesv
transform
cell
denoronha
et
al
vaccin
protect
system
measur
criteria
reduct
maximum
tumor
size
hunsmann
et
al
decreas
proport
cat
develop
progress
grow
fatal
fibrosarcoma
decreas
proport
infect
cat
develop
persist
felv
helper
viremia
cours
tumor
growth
tumor
regress
second
challeng
system
cat
inocul
oronas
focu
form
unit
ffu
everi
day
day
similarli
ffu
rfelv
propag
leopard
cat
testicl
cell
rashe
et
al
rfelv
propag
felin
fibroblast
viru
titrat
focu
format
procedur
fisching
associ
system
vaccin
protect
measur
decreas
proport
cat
still
virem
week
post
challeng
pedersen
et
al
retroviremia
measur
weekli
use
elisa
procedur
detect
effect
vaccin
post
challengeexposur
incid
persist
viremia
evalu
use
rel
odd
ratio
glantz
degre
freedom
x
greater
consid
signific
confid
level
p
analyz
puriti
inmnoblot
acord
procedur
towbin
associ
except
enzymat
reaction
develop
use
mgml
tetrahydrochlorid
monohydr
aldrich
chemic
milwauke
wi
hydrogen
peroxid
tri
salin
buffer
ph
singl
band
molecular
weight
dalton
identifi
prepar
use
mous
monoclon
antibodi
fig
absent
prepar
contain
dalton
band
react
mous
monoclon
antibodi
figur
irmnunoblot
pa
purifi
deterg
disrupt
whole
felv
mous
monoclon
antibodi
run
reduc
condit
demonstr
major
band
monoclon
antibodi
dalton
major
band
felvpls
monoclon
antibodi
dalton
irmmncblot
whole
felv
react
monoclon
reagent
demonstr
correspond
band
reactiv
dalton
region
respect
prepar
found
react
monoclon
antibodi
free
plse
specif
control
also
test
immunoblot
detect
correspond
monoclon
antibodi
subject
number
physic
chemic
insult
purif
import
therefor
determin
whether
major
antigen
epitop
still
intact
major
antigen
epitop
describ
nunberg
cowork
epitop
contain
amino
acid
region
aminotermin
half
recogn
monoclon
antibodi
determin
whether
epitop
still
intact
purifi
use
competitor
bind
peroxidas
label
monoclon
antibodi
whole
felv
elisa
assay
deterg
disrupt
whole
felv
compet
label
monoclon
antibodi
bind
whole
felv
fig
purifi
also
react
elisa
batteri
differ
mous
monoclon
antibodi
goat
polyclon
serum
tabl
purifi
react
antibodi
tabl
ii
iii
figur
elisa
antibodi
titer
serum
cat
vaccin
inactiv
whole
felv
vaccin
antibodi
respons
group
anim
consid
repres
respons
seen
group
whole
upper
graph
depict
serum
antibodi
level
purifi
lower
graph
depict
antibodi
level
whole
deterg
disrupt
felv
control
cat
develop
appreci
elisa
antibodi
titer
therefor
includ
cat
immun
inactiv
whole
stfelv
vaccin
regardless
experiment
group
resist
virul
viru
challeng
greater
degre
control
nonimmun
anim
tabl
ii
case
kitten
challeng
stfesv
tabl
efficaci
subunit
vaccin
forti
weekold
kitten
vaccin
purifi
felv
envelop
protein
tabl
v
thirtyseven
kitten
serv
nonvaccin
control
cat
immun
variou
felv
envelop
protein
produc
good
serum
antibodi
whole
felv
detect
elisa
fig
viru
neutral
antibodi
detect
howev
serum
vaccin
cat
data
shown
elisa
antibodi
titer
serum
cat
vaccin
immunoaffin
column
purifi
antibodi
respons
group
anim
consid
repres
respons
seen
group
whole
upper
graph
depict
serum
antibodi
level
purifi
lower
graph
depict
antibodi
level
whole
deterg
disrupt
felv
control
cat
develop
appreci
elisa
antibodi
titer
therefor
includ
two
week
complet
cours
immun
subunit
vaccidt
cat
control
anim
challeng
either
felv
fesv
follow
inocul
fesv
vaccin
nonvaccin
develop
fibrosareoma
site
inocul
tabl
iv
mean
peak
tumor
size
alway
smaller
cat
vaccin
surprisingli
proport
cat
remain
persist
felvhelp
virem
follow
fesv
inocul
mirror
decreas
tumor
growth
vaccin
remain
persist
retrovirem
follow
challengeexposur
higher
rate
oontrol
anim
vs
r
x
p
tabl
v
twenti
felv
vaccin
nonvaccin
kitten
challeng
oronas
virul
felv
tabl
vi
follow
challengeexposur
greater
proport
vaccin
cat
becam
persist
virem
compar
nonvaccin
vs
x
p
although
differ
chisquar
statist
signific
upper
graph
depict
antibodi
level
purifi
lower
graph
depict
antibodi
titer
deterg
disrupt
whole
felv
nonvaccin
control
cat
develop
appreci
antibodi
titer
therefor
includ
overal
enhanc
persist
retroviremia
vaccin
purifi
felv
envelop
protein
seen
experiment
group
e
contrast
ii
group
cat
vaccin
inactiv
whole
felv
vaccin
show
lower
incid
persist
viremia
nonvaccin
within
experi
salerno
associ
conclud
purifi
poorli
immunogen
cat
induc
antibodi
detect
radioiaunoassay
littl
viru
neutral
cytotox
antibodi
experi
confirm
find
none
cat
immun
either
develop
viru
neutral
antibodi
serum
antibodi
detect
elisa
produc
whole
felv
surpris
find
studi
cat
vaccin
appear
suscept
infect
virul
felv
fesv
nonvaccin
anim
enhanc
infect
seen
vaccin
group
appar
whether
cat
immun
also
occur
regardless
whether
challeng
virus
autolog
homolog
strain
felv
purifi
envelop
protein
extract
find
oppos
therefor
immunoprotect
effect
viral
envelop
protein
vaccin
demonstr
murin
leukemia
viru
infect
hunemnn
et
al
hunemnn
et
al
bovin
leukemia
viru
infect
sheep
onuma
et
al
footandmouth
diseas
cattl
bittl
et
al
enhanc
rather
protect
effect
vaccin
could
due
sever
mechan
first
possibl
procedur
use
purifi
protein
alter
antigen
way
neutral
epitop
longer
present
seem
unlik
howev
purifi
compet
equal
well
whole
felv
bind
mous
monoclon
antibodi
antibodi
recogn
major
neutral
epitop
felv
envelop
protein
nunberg
et
al
addit
purifi
immunoreact
elisa
viru
neutral
mous
monoclon
antibodi
highli
specif
goat
polyclon
felv
neutral
antibodi
second
explan
possibl
enhanc
effect
purifi
envelop
protein
vaccin
fail
induc
spectrum
inmlan
essenti
protect
ie
neutral
antibodi
well
cellular
imsniti
neutral
antibodi
might
gener
result
exposur
larger
envelop
polyprotein
precleavag
product
present
inmatur
particl
cell
membran
role
cellular
immun
felv
infect
larg
unknown
passiv
transfer
immun
sera
greatli
inhibit
retroviremia
follow
experiment
infect
cat
denorohna
et
al
suggest
humor
immun
inort
clearanc
viru
blood
felin
leukemia
viru
persist
bodi
latent
infect
howev
even
face
strong
humor
immun
cellular
iman
implic
ultim
clearanc
latent
infect
viru
system
inun
hard
evok
kill
subunit
protein
third
explan
nonneutr
antibodi
envelop
protein
might
either
interf
immun
enhanc
effect
viru
infect
spread
nonneutr
antibodi
might
bound
viru
steric
block
bind
viru
neutral
antibodi
induc
result
virul
viru
challengeexposur
massey
schochetman
nonneutr
antibodi
may
act
opsonin
enhanc
uptak
antibodi
coat
viru
phagocyt
cell
felv
replic
initi
phagocyt
cell
lymph
node
region
site
entri
spread
organ
target
tissu
via
blood
born
mononuclear
cell
rojko
et
al
felv
grow
well
mononuclear
cell
mononuclear
cell
migrat
throughout
bodi
increas
viru
uptak
phagocyt
cell
could
lead
increas
viru
infect
dissemin
scheme
without
preced
dengu
viru
infect
man
enhanc
preexist
humor
immun
homolog
serotyp
dengu
viru
relat
flaviviru
infect
porterfield
similar
manner
felin
infecti
periton
fip
viru
infect
also
potenti
preexist
homolog
coronaviru
antibodi
vaccin
fip
viru
also
make
experiment
induc
diseas
wors
rather
better
final
possibl
envelop
protein
act
immunosuppres
rather
imunogen
reportedli
caus
inmunosuppress
vitro
vivo
math
et
al
cat
immun
receiv
plse
plse
moieti
may
enhanc
infect
virul
felv
challeng
virtu
immunosuppress
effect
support
shown
previous
felvpls
given
along
felv
vaccin
render
cat
susoept
fesv
challeng
receiv
vaccin
alon
math
et
al
phenomena
howev
explain
find
cat
immun
hypersensit
infect
cat
immmiz
obviou
question
rais
find
whether
immiti
felv
induc
vaccin
current
find
salerno
associ
salerno
et
al
univers
applic
answer
seem
possibl
howev
would
induc
protect
immun
given
form
dose
adjuv
possibl
answer
without
great
deal
addit
research
point
overlook
howev
mani
research
place
great
hope
subunit
vaccin
produc
genet
engin
bacteria
yeast
synthet
oligopeptid
find
indic
mani
problem
uncertainti
exist
approach
convent
inactiv
whole
viru
vaccin
necessarili
bypass
sake
modern
techniqu
although
vaccin
enhanc
persist
retroviremia
significantli
reduc
growth
rate
retroviru
induc
fibrosarcoma
inmniti
would
protect
tumor
yet
enhanc
retroviremia
immedi
understand
known
howev
fibrosarcoma
retroviru
inmniti
distinctli
differ
phenomena
denoronha
et
al
dichotomi
tumor
antiviru
immun
vaccin
cat
therefor
incompat
known
fesv
immun
although
current
outlook
cheap
effect
felv
vaccin
recombin
synthet
origin
somewhat
cloud
must
note
convent
formalin
inactiv
whole
viru
vaccin
work
well
l
djuvant
inactiv
whole
viru
vaccin
dose
ml
eq
decreas
postinfect
persist
viremia
rate
studi
c
mparabl
result
earlier
trial
similar
dose
antigen
natur
contact
challeng
exposur
pedersen
et
al
fact
whole
inactiv
felv
immtmogen
induc
protect
immmiti
immunogen
indic
either
protein
viru
respons
protect
immun
envelop
protein
favor
array
immunogen
whole
viru
suspens
pure
protein
result
previou
studi
indic
antibodi
protein
addit
also
correl
protect
lutz
et
al
thu
support
first
premis
support
latter
possibl
felv
viron
known
incorpor
small
amount
meran
protein
bud
infect
cell
azocar
et
al
host
protein
may
enhanc
immunogenec
viral
protein
anoth
possibl
dose
use
studi
lower
present
mg
whole
felv
viral
protein
whole
felv
mg
whole
viru
would
contain
ug
use
mg
per
dose
vaccin
experi
seem
therefor
differ
efficaci
whole
viru
subunit
protein
vaccin
due
differ
rel
amount
envelop
protein
experi
seem
firsthand
contradictori
recent
report
osterhau
cowork
abl
induc
low
level
viru
neutral
antibodi
young
cat
immun
dose
ostimul
complex
iscom
contain
moreov
cat
seem
much
resist
experiment
induc
felv
infect
nonvaccin
control
anim
even
author
howev
care
ascrib
protect
effect
vaccin
sole
envelop
protein
content
iscom
made
disrupt
whole
viru
induc
antibodi
wide
rang
envelop
nonenvelop
protein
effect
studi
osterhau
associ
reconfirm
studi
whole
viru
vaccin
prove
envelop
protein
alon
respons
protect
immun
demonstr
iscom
prepar
cat
vaccin
iscom
contain
envelop
protein
alon
prepar
prove
protect
iscom
made
whole
viru
conced
experi
envelop
protein
vaccin
jade
adjuv
use
brown
protect
footarmouth
diseas
immun
chemic
synthes
peptid
predict
viral
nucleotid
sequenc
natur
